Olpha Competitors and Similar CompaniesClear all
Olpha's competitors and similar companies include Oxurion.
 Olpha Olpha (formerly known as Olainfarm) is a company engaged in the development and manufacture of pharmaceutical products. |  Oxurion Oxurion (formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye. | |
Founding Date | Founding Date 1972 | Founding Date 1991 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Olaine, LV HQ | Locations Leuven, BE HQ Dublin 8, IE |
Employees | Employees 2,191 | Employees 785% increase |
Financial | ||
Revenue (est.) | Revenue (est.) €122.2m (FY, 2020) | Revenue (est.) €555k (FY, 2025) |
Cost of goods | Cost of goods €44.5m (FY, 2020) | Cost of goods N/A |
Gross profit | Gross profit €80.1m (FY, 2020) | Gross profit €937k (FY, 2025) |
Net income | Net income €9.5m (FY, 2020) | Net income (€3.7m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Oxurion
HQ
Leuven, BE
Employees
78↑ 5% increase
Oxurion (formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye.
View company